CA2239205A1 - Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif - Google Patents
Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif Download PDFInfo
- Publication number
- CA2239205A1 CA2239205A1 CA 2239205 CA2239205A CA2239205A1 CA 2239205 A1 CA2239205 A1 CA 2239205A1 CA 2239205 CA2239205 CA 2239205 CA 2239205 A CA2239205 A CA 2239205A CA 2239205 A1 CA2239205 A1 CA 2239205A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- sod
- disease
- reactive oxygen
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2239205 CA2239205A1 (fr) | 1998-05-29 | 1998-05-29 | Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif |
| CA 2273173 CA2273173A1 (fr) | 1998-05-29 | 1999-05-28 | Prolongation de la longevite par la surexpression d'un gene qui accroit le metabolisme reactif d'oxygene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2239205 CA2239205A1 (fr) | 1998-05-29 | 1998-05-29 | Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2239205A1 true CA2239205A1 (fr) | 1999-11-29 |
Family
ID=29275805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2239205 Abandoned CA2239205A1 (fr) | 1998-05-29 | 1998-05-29 | Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2239205A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2698153A1 (fr) * | 2001-12-18 | 2014-02-19 | Brassica Foundation for Chemoprotection Research, Inc. | Prévention et traitement d'affections liées au stress oxydatif par des composés qui augmentent les niveaux intracellulaires de glutathione ou des enzymes de détoxification de phase II |
| CN117316295A (zh) * | 2023-09-13 | 2023-12-29 | 哈尔滨工业大学 | 一种基于细胞异质性基因与通路功能的内分泌疾病细胞识别方法 |
-
1998
- 1998-05-29 CA CA 2239205 patent/CA2239205A1/fr not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2698153A1 (fr) * | 2001-12-18 | 2014-02-19 | Brassica Foundation for Chemoprotection Research, Inc. | Prévention et traitement d'affections liées au stress oxydatif par des composés qui augmentent les niveaux intracellulaires de glutathione ou des enzymes de détoxification de phase II |
| CN117316295A (zh) * | 2023-09-13 | 2023-12-29 | 哈尔滨工业大学 | 一种基于细胞异质性基因与通路功能的内分泌疾病细胞识别方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parkes et al. | Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons | |
| Seto et al. | Overexpression of Cu-Zn superoxide dismutase in Drosophila does not affect life-span. | |
| Schwarze et al. | Oxidative stress and aging reduce COX I RNA and cytochrome oxidase activity in Drosophila | |
| Morrow et al. | Overexpression of the small mitochondrial Hsp22 extends Drosophila life span and increases resistance to oxidative stress | |
| Dufour et al. | Understanding aging: revealing order out of chaos | |
| Aigaki et al. | Longevity determination genes in Drosophila melanogaster | |
| Wallace | Animal models for mitochondrial disease | |
| Morrison et al. | Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death | |
| Phillips et al. | Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. | |
| Felkai et al. | CLK‐1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans | |
| Melov et al. | Mouse models of mitochondrial disease, oxidative stress, and senescence | |
| Pandolfo | Molecular genetics and pathogenesis of Friedreich ataxia | |
| Garzino et al. | Cell lineage‐specific expression of modulo, a dose‐dependent modifier of variegation in Drosophila. | |
| Kim et al. | Transcriptional regulation and life-span modulation of cytosolic aconitase and ferritin genes in C. elegans | |
| Kunst et al. | Genetic mapping of a mouse modifier gene that can prevent ALS onset | |
| JP2020010707A (ja) | snoRNA、組成物、及び使用 | |
| Quintero-Espinosa et al. | Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson’s disease | |
| Huen et al. | Dynamic regulation of molecular chaperone gene expression in polyglutamine disease | |
| Wynen et al. | Cisplatin-induced DNA crosslinks trigger neurotoxicity in C. elegans | |
| CA2239205A1 (fr) | Prolongation de la duree de vie par surexpression d'un gene qui augmente le metabolisme d'oxygene reactif | |
| Ayajuddin | Parkinson’s disease: Insights from Drosophila model | |
| CA2273173A1 (fr) | Prolongation de la longevite par la surexpression d'un gene qui accroit le metabolisme reactif d'oxygene | |
| Manev | 5-Lipoxygenase gene polymorphism and onset of Alzheimer's disease | |
| Asencio et al. | Coenzyme Q supports distinct developmental processes in Caenorhabditis elegans | |
| Hanada et al. | Cyclosporin A inhibits thyroid hormone-induced shortening of the tadpole tail through membrane permeability transition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |